Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Actinomycin D and Vincristine With or Without Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Rhabdomyosarcoma or Undifferentiated Sarcoma: IRS-V Protocol

NCT00002995 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00002995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Actinomycin D and Vincristine With or Without Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Rhabdomyosarcoma or Undifferentiated Sarcoma: IRS-V Protocol
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
August 31, 1997
Completion date
January 31, 2011
Enrollment
483 (actual)
Sites
233

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma